U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Name Type Language
DARATUMUMAB-FIHJ
FDA  
Preferred Name English
DARATUMUMAB-FIHJ COMPONENT OF DARZALEX FASPRO
Brand Name English
DARZALEX FASPRO COMPONENT DARATUMUMAB-FIHJ
Brand Name English
Code System Code Type Description
BIOLOGIC SUBSTANCE CLASSIFICATION CODE
4Z63YK6E0E-FIHJ-01
Created by admin on Fri Dec 15 19:09:25 UTC 2023 , Edited by admin on Fri Dec 15 19:09:25 UTC 2023
PRIMARY
SUBSTANCE RECORD
DARATUMUMAB-FIHJ
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966